Get started
Author

Alexander Meleshko

Observed names: A N Meleshko, A. Meleshko, A. N. Meleshko, A.N. Meleshko, ALEXANDER MELESHKO, Alexander N. Meleshko, Alexander Nikolayevich Meleshko, А. Мелешко, А. Н. Мелешко, А.Н. Мелешко, Мелешко А. Н., Мелешко, А. Н.
ORCID: 0000-0001-6964-3635
Observed ORCID: 0000-0001-6964-3635
OpenAlex ID: A5086827372
Phase I clinical trial of idiotypic DNA vaccine administered as a complex with polyethylenimine to patients with B-cell lymphoma
2017 · A. N. Meleshko, N. A. Petrovskaya, et al. · Human Vaccines & Immunotherapeutics · 48
PDF
Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma
2018 · Alexey V. Stepanov, Oleg V. Markov, et al. · Science Advances · 28
Multi-antigen DNA vaccine delivered by polyethylenimine and Salmonella enterica in neuroblastoma mouse model
2020 · Maria V. Stegantseva, Veronika A. Shinkevich, et al. · Cancer Immunology Immunotherapy · 24
Relative expression of different Ikaros isoforms in childhood acute leukemia
2008 · Alexander N. Meleshko, Ludmila V. Movchan, et al. · Blood Cells Molecules and Diseases · 22
CAR-T Cell Therapy for Classical Hodgkin Lymphoma
2023 · Mikalai Katsin, Dmitri Dormeshkin, et al. · HemaSphere · 20
Prognostic value of MRD-dynamics in childhood acute lymphoblastic leukemia treated according to the MB-2002/2008 protocols
2011 · Alexander N. Meleshko, Natalia N. Savva, et al. · Leukemia Research · 20
The incidence of T-cell receptor gene rearrangements in childhood B-lineage acute lymphoblastic leukemia is related to immunophenotype and fusion oncogene expression
2006 · Alexander N. Meleshko, Michael V. Belevtsev, et al. · Leukemia Research · 16
Rearrangements of IgH, TCRD and TCRG genes as clonality marker of childhood acute lymphoblastic leukemia.
2005 · A N Meleshko, N V Lipay, et al. · PubMed · 16
State of the art and perspectives of chimeric antigen receptor T cells cell therapy for neuroblastoma
2024 · Dzmitry Lutskovich, Alexander Meleshko, et al. · Cytotherapy · 14
Isolation of an escape-resistant SARS-CoV-2 neutralizing nanobody from a novel synthetic nanobody library
2022 · Dmitri Dormeshkin, Michail Shapira, et al. · Frontiers in Immunology · 14
Chimerism of allogeneic mesenchymal cells in bone marrow, liver, and spleen after mesenchymal stem cells infusion
2013 · Alexander Meleshko, Irina Prakharenia, et al. · Pediatric Transplantation · 11
Safety and Immunogenicity of Combined DNA-Polyethylenimine and Oral Bacterial Idiotypic Vaccine for Patients with B-Cell Non-Hodgkin Lymphoma: A Pilot Study
2022 · Alexander Meleshko, Nadzeya Piatrouskaya, et al. · Cancers · 8
PDF
Conjugation of new DNA vaccine with polyethylenimine induces cellular immune response and tumor regression in neuroblastoma mouse model
2020 · M.V. Stegantseva, V.A. Shinkevich, et al. · Experimental Oncology · 8
PDF
Expression of aberrantly spliced oncogenic Ikaros isoforms coupled with clonal IKZF1 deletions and chimeric oncogenes in acute lymphoblastic leukemia
2018 · Volha Vshyukova, Alena Valochnik, et al. · Blood Cells Molecules and Diseases · 8
Expression Pattern of Tumor-associated Antigens in Neuroblastoma: Association With Cytogenetic Features and Survival
2023 · ALEXANDER MELESHKO, LIZAVETA KUSHNIAROVA, et al. · Cancer Diagnosis & Prognosis · 5
PDF
Expansion and Activation of Human Natural Killer Cells ex vivo in the Presence of Transgenic Feeder Cells
2020 · E. P. Vashkevich, A. A. Migas, et al. · Cell and Tissue Biology · 5
Pilot clinical trial of DNA vaccination against neuroblastoma: study design and preliminary results
2024 · I. V. Proleskovskaya, A. N. Meleshko, et al. · Russian Journal of Pediatric Hematology and Oncology · 3
PDF
Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein
2023 · Dmitri Dormeshkin, Mikalai Katsin, et al. · Vaccines · 3
PDF
Knockout of the T-cell receptor and HLA class I genes in human cells using the CRISPR /Cas9 system
2022 · Lizaveta V. Kushniarova, Alexandr A. Migas, et al. · Experimental Biology and Biotechnology · 3
Aberrant IKZF1 gene as relapse predictor in standard‐risk pediatric patients with B‐cell precursor acute lymphoblastic leukaemia
2022 · Volha Sergeevna Vshyukova, Olga Vladimirovna Krasko, et al. · International Journal of Laboratory Hematology · 3
Changing of IKZF1 genotype during Philadelphia-negative precursor-B acute lymphoblastic leukemia progression: a short clinical report
2016 · Volha Vshyukova, Alexander Meleshko, et al. · Leukemia Research Reports · 3
PDF
Response Monitoring in Follicular Lymphoma by Synchronous Evaluation of Minimal Residual Disease and Diffusion-weighted Mri
2015 · A N Meleshko, S A Kharuzhyk, et al. · Experimental Oncology · 3
PDF
Cloning of variable fragments of tumor immunoglobulin, assembling and expressing of human SCFV protein in E. coli for anti-idiotype vaccination.
2013 · A N Meleshko, K P Vashkevich, et al. · PubMed · 3
CD19 CAR T cell therapy BY19 for pediatric and adult patients with relapsed or refractory B cell neoplasms in Belarus: Phase 1 trial
2025 · Mikalai Katsin, Dmitri Dormeshkin, et al. · Molecular Therapy Oncology · 2
PDF
Comparative Preclinical Analysis of Anti-B7-H3 CAR-T Cells Targeting Neuroblastoma
2025 · Dzmitry V. Lutskovich, Alexander N. Meleshko, et al. · Biomedicines · 2
PDF
Works count: 50
Citation count: 301
H-index: 11
I10-index: 11
Year
Topic
Type